載入...
Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
Renal cell carcinoma encompass distinct diseases with different pathologic features and distinct molecular pathways. Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) pathway alone or in combination have greatly changed clinical...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480014/ https://ncbi.nlm.nih.gov/pubmed/30987368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20071692 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|